Navigation Links
Biochemists uphold law of physics
Date:7/15/2013

Experiments by biochemists at the University of California, Davis show for the first time that a law of physics, the ergodic theorem, can be demonstrated by a collection of individual protein molecules -- specifically, a protein that unwinds DNA. The work will be published online by the journal Nature on July 14.

Using technology invented at UC Davis for watching single enzymes at work, Bian Liu, a graduate student in the Biophysics Graduate Group and professor Steve Kowalczykowski, Department of Microbiology and Molecular Genetics and UC Davis Cancer Center, found that when they paused and restarted a single molecule of the DNA-unwinding enzyme RecBCD, it could restart at any speed achieved by the whole population of enzymes.

"It's pretty impressive," said Daniel Cox, a physics professor at UC Davis who was not involved in the work. "The laws of physics should apply to biological systems, and it turns out they do."

The results also have implications for understanding how proteins fold into their correct shape, for exploring interactions between drugs and their targets, and for engineering enzymes for new functions.

The ergodic theorem, proposed by mathematician George Birkhoff in 1931, holds that if you follow an individual particle over an infinite amount of time, it will go through all the states that are seen in an infinite population at an instant in time. It's a fundamental assumption in statistical mechanics -- but difficult to prove in an experiment.

Liu and Kowalczykowski weren't attempting to test laws of physics when they began the work. They wanted to know why RecBCD, an enzyme that unwinds DNA in E. coli bacteria, showed so much variability in its rate of action.

RecBCD attaches to and moves along DNA, unwinding the double helix into two separate strands. It has two jobs in the cell: to allow damaged DNA to be repaired, and to break down invading "foreign" DNA from viruses.

In 2001, Kowalczykowski's laboratory, with the late professor Ronald Baskin at UC Davis, developed a technique to trap single molecules of RecBCD and watch them at work on a strand of DNA in real time. They have since exploited the method to study how DNA is repaired -- in humans, a vital process in protecting against cancer and developmental defects.

"Ever since the original experiments, we've noticed RecBCD molecules have quite a broad range of speeds," Kowalczykowski said.

Liu used the single-molecule visualization technique to measure the rates of hundreds of RecBCD molecules, finding bell-shaped curves for the whole population.

One explanation could be that a large proportion of the proteins were not folded properly and were "trapped" in an inefficient state. However, mild heat or unfolding treatments, which should have allowed the proteins to relax into their correct folded state, had no effect.

RecBCD usually runs for about a minute before stopping spontaneously. Liu found that he could stop the enzyme early by taking away ATP, the chemical fuel that makes the enzyme work.

When he brought back the fuel, he found that the enzymes started up again -- but at a random speed, not related to their previous rate. Overall, the individual RecBCD proteins could restart at any speed within the bell-shaped spread shown by all the proteins.

The experiment shows that RecBCD can move through a wide range of slightly different conformations in which it works at slightly different speeds. However, when it is attached to a step on the DNA ladder, it is locked in shape. Because the time for the enzyme to move from step to step along DNA is shorter than the time it needs to change conformation (about one second), it remains in the same conformation as long as it is moving along DNA, Kowalczykowski said.

What is the point? Why not just have all the enzymes work at one, optimal rate? Having this important enzyme able to operate at a range of speeds might give the cell flexibility to respond to rapidly changing conditions, Kowalczykowski said. For example, degradation of foreign DNA is a process that needs to go quite fast: copying and repairing DNA might require the enzyme to work more slowly, in combination with other proteins.


'/>"/>

Contact: Andy Fell
ahfell@ucdavis.edu
530-752-4533
University of California - Davis
Source:Eurekalert

Related biology news :

1. UMass Amherst biochemists developing tools to stop plague and other bacterial threats
2. Wayne State welcomes undergraduates from around the US for physics research experience
3. Discovery of new material state counterintuitive to laws of physics
4. Frontiers launches new open-access journal in physics
5. UT Arlington physics team demonstrates new power generation technique
6. New book on physics principles by Wayne State professor explains life as we know it
7. How a fish broke a law of physics
8. Physics and math shed new light on biology by mapping the landscape of evolution
9. Physics confirms sprinters are performing better than ever before
10. The physics of going viral
11. T cells hunt parasites like animal predators seek prey, a Penn Vet-Penn Physics study reveals
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/27/2017)... March 27, 2017  Catholic Health Services (CHS) ... Systems Society (HIMSS) Analytics for achieving Stage 6 ... sm . In addition, CHS previously earned a ... using an electronic medical record (EMR). ... level of EMR usage in an outpatient setting.  ...
(Date:3/24/2017)... Research and Markets has announced the addition ... Trends - Industry Forecast to 2025" report to their offering. ... The Global Biometric ... of around 15.1% over the next decade to reach approximately $1,580 ... market estimates and forecasts for all the given segments on global ...
(Date:3/23/2017)... , Mar. 23, 2017 Research and ... System Market Analysis & Trends - Industry Forecast to 2025" ... ... grow at a CAGR of around 8.8% over the next decade ... industry report analyzes the market estimates and forecasts for all the ...
Breaking Biology News(10 mins):
(Date:8/10/2017)... ... August 09, 2017 , ... ... in the clinic is here. The team at Capricor Therapeutics, Inc. utilized a ... for clinical studies. , Dr. Travis Antes, head of analytical development at ...
(Date:8/10/2017)... SAN DIEGO, California, USA (PRWEB) , ... August ... ... and photonics, has partnered with four international biomedical optics laboratories — the Wellman ... Massachusetts General Hospital, Medical Laser Center Lübeck and the Beckman Laser Institute at ...
(Date:8/10/2017)... Coral Springs, FL (PRWEB) , ... August 10, ... ... today announced that the stock market news outlet had initiated coverage on Next ... the rapidly growing and underserved consumer markets geared toward those that cannot engage ...
(Date:8/8/2017)... ... August 08, 2017 , ... HumanZyme Inc., a leading ... today announced the launch of HumanKine® Interferon beta (IFN beta) expressed ... interferons that activate Th1-type innate immune responses against viral and bacterial infection, and have ...
Breaking Biology Technology: